BMC Medicine

official impact factor 5.75

Open Access Highly Access Review

Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future

Philipp Schuetz*, Werner Albrich and Beat Mueller

BMC Medicine 2011, 9:107 doi:10.1186/1741-7015-9-107

Accesses  

  • Last 30 days: 1138 accesses
  • Last 365 days: 8466 accesses
  • All time: 8466 accesses

Cited by

BioMed Central: 2 citations

Minireview   Open Access Highly Accessed

suPAR as a prognostic biomarker in sepsis

Katia Donadello, Sabino Scolletta, Cecilia Covajes, Jean-Louis Vincent BMC Medicine 2012, 10:2 (5 January 2012)

This article is part of a collection on Clinical biomarkers

Donadello and colleagues review the clinical utility of suPAR as a biomarker for sepsis, and discuss how it can be used to monitor response to treatment in critically ill patients.

Research   Open Access

The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - a DRG-based simulation model

MH Wilke, RF Grube, KF Bodmann European Journal of Medical Research 2011, 16:543-548 (2 December 2011)